Back to News
May 5, 2026 4:42 PM

Corteva Delivers Strong 1Q 2026, Reaffirms 2026 Outlook, On-Track for 4Q 2026 Separation

First quarter sales reflect strength of Seed and Crop Protection technology portfolios and progress on growth platforms

Continued productivity and cost initiatives across both businesses further improve financial position

Full-year 2026 guidance3 reaffirmed, including progress on 2027 value framework

INDIANAPOLIS, Ind., May 5, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE:CTVA) ("Corteva" or the "Company") today reported financial results for the first quarter ended March 31, 2026.

1Q 2026 Results Overview

Net Sales

Inc. from Cont. Ops (After Tax)     

EPS

GAAP

$4.90B

$725M

$1.07

vs. 1Q 2025     

11 %

9 %

10 %

Organic1 Sales     

Operating EBITDA1

Operating EPS1

NON-GAAP

$4.73B

$1.44B

$1.50

vs. 1Q 2025

7 %

21 %

33 %

First Quarter 2026 Highlights

First quarter 2026 net sales increased 11% versus prior year.  Organic1 sales increased 7% in the same period.

Seed net sales increased 12% and organic1 sales increased 9%.  Price/mix was up 3%, with gains in all regions, led by favorable product mix and continued execution on the Company's price for value strategy.  Volume growth in North America2 was driven by seasonal timing shifts in seed deliveries.

Crop Protection net sales increased 10% and organic1 sales increased 4%. Price declined 2% due to competitive market dynamics in Latin America.  Volume improved 6%, with gains in all regions, driven by demand for new products.

GAAP income and earnings per share (EPS) from continuing operations were $725 million and $1.07 per share, respectively.

Operating EBITDA1 and Operating EPS1 were $1.44 billion, and $1.50 per share, respectively.

The Company reaffirmed full-year 2026 guidance3 and expects Operating EBITDA1 to be in the range of $4.0 to $4.2 billion.  Operating EPS1 is expected to be $3.45 to $3.70 per share. 

The Company plans to repurchase approximately $500 million of shares during the first half of 2026.

1Q   

1Q  

%

%

($ in millions, except where noted)     

2026

2025

Change

   Organic1 Change

Net Sales

$4,905

$4,417

11 %

7 %

North America

$2,439

$2,210

10 %

10 %

EMEA

$1,655

$1,477

12 %

4 %

Latin America

$506

$442

14 %

4 %

Asia Pacific

$305

$288

6 %

5 %

1.

Organic Sales, Operating EPS, and Operating EBITDA are non-GAAP measures. See page 5 for further discussion. 2. North America is defined as U.S. and Canada. EMEA is defined as Europe, Middle East and Africa. 3. The Company does not provide the most comparable GAAP measure on a forward-looking basis. See page 4 for further discussion. 4. One-time separation costs do not include deferred asset expenses related to debt issuance costs to be amortized/incurred as future interest payments.

______________________________________________________________________________________

"In the first quarter, Corteva delivered a strong start to the year, delivering growth across both businesses and all regions.  Our performance reflects a solid start to the season in the Northern Hemisphere coupled with disciplined cost management and continued demand for our advanced technology, all of which allowed us to deliver earnings growth and margin expansion. 

We also made good progress on our separation, naming executive leadership teams for both future companies, filing our initial Form 10, and announcing Vylor, the new name for our future advanced seed and genetics company.  We remain focused on launching two strong companies, on track for the fourth quarter, and on delivering our 2026 targets.  Our future is bright. "

Chuck MagroChief Executive Officer

______________________________________________________________________________________

Company Updates

Separation Update: Key Milestone Targets

Corteva remains on track to complete the planned separation in the second half of 2026, with already announced key milestones

Announced Luke Kissam as New Corteva CEO, along with other key executive leadership roles

Vylor was announced as the name of the future advanced seed and genetics company

Initial Form 10 filed with the SEC, due to regulatory requirements, Vylor will be shown as the continuing operations of Corteva, Inc. with New Corteva presented as discontinued operations

One-time separation costs4 expected to be ~$350 million, consistent with external benchmark ranges

Net dis-synergies estimate of ~$100 million trending favorably; $50 million included in full-year 2026 guidance

In April 2026, the Board of Directors approved a discretionary contribution to the principal U.S. pension plan of approximately $1.5 billion (on a pre-tax basis) to be made on or before July 31, 2026. The company continues to expect both companies at separation to have strong balance sheets and investment grade credit ratings.

Key separation milestones still expected to be achieved in the first ...